CIPLA LTD
NSE₹1,424.10·CIPLA·INE059A01026
Previous session · source 2026-09-19SnapshotPrice chart
fast lightweight viewCIPLA 1M line chart. 14 bars, from 1,409.2 to 1,394.5, down 1.04 percent.
Market depth
live order bookBuy orders32.33%Sell orders67.67%
| Bid Price | Qty | Ask Price | Qty |
|---|---|---|---|
| 1,352.00BSE | 32 | 1,352.30NSE | 29 |
| 1,351.95BSE | 25 | 1,352.40NSE | 6 |
| 1,351.90BSE | 44 | 1,352.50NSE | 94 |
| 1,351.75BSE | 32 | 1,352.60NSE | 77 |
| 1,351.70BSE | 26 | 1,352.70NSE | 129 |
| 1,351.70NSE | 82 | 1,352.90BSE | 12 |
| 1,351.60NSE | 93 | 1,352.95BSE | 44 |
| 1,351.50NSE | 25 | 1,353.00BSE | 873 |
| 1,351.40NSE | 124 | 1,353.05BSE | 15 |
| 1,351.30NSE | 131 | 1,353.10BSE | 6 |
| Bid Total | 614 | Ask Total | 1,285 |
- 1,355.00
- Open
- 1,362.70
- High
- 1,347.70
- Low
- 1,424.10
- Close
Performance
Today’s lowToday’s high
₹1,347.70₹1,362.70
52-week low52-week high
₹1,344.30₹1,426.10
Open₹1,355.00
Prev close₹1,424.10
Volume6.26 L
Latest dividend₹13 · 05 Jun 26
Investor snapshot
fast read from available feedsPrice positionRange unavailableQuote unavailable
Profitability15%Latest ROCE
Growth+2.23%Revenue YoY, latest annual
Ownership29.2% promoterLatest shareholding
DerivativesF&O availableOption chain linked
Use this as a navigation aid. It summarizes feed observations, not a buy or sell view.
Financials
₹ croreRevenue and profit growth
latest Mar 2026Revenue growth
1Y+2.23%
3Y CAGR+7.37%
Net profit growth
1Y−26.70%
3Y CAGR+10.88%
Historical returns
computed from available OHLC1DNot available
1W+2.09%
1M−1.04%
3M−1.04%
6M−1.04%
1Y−1.04%
Company profile
Public company in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ListedTrue
Founded1935
HeadquartersMumbai, Maharashtra, India
ISININE059A01026
Cipla Limited is an Indian multinational pharmaceutical company that manufactures, develops, sells, and distributes branded medicines, generics, active pharmaceutical ingredients, and related healthcare products. It operates through Pharmaceuticals and New Ventures segments and has a significant presence in India and international markets including South Africa and the United States.
- Founded in 1935 by Khwaja Abdul Hamied.
- Publicly listed company on the BSE and NSE, with ticker symbol CIPLA on NSE and 500087 on BSE.
- Headquartered in Mumbai, Maharashtra, India.
- Operates in pharmaceuticals, consumer healthcare, biosimilars, and specialty businesses.